*
|
The
remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a
prior cover page.
|
CUSIP
No. 987537206
|
13D
|
Page
2 of 6
Pages
|
(1)
|
NAMES
OF REPORTING PERSONS
Carl
Grover
|
|||||
(2)
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see
instructions)
(a)
☐ (b) ☐
|
|||||
(3)
|
SEC USE
ONLY
|
|||||
(4)
|
SOURCE
OF FUNDS (see instructions)
PF
|
|||||
(5)
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
2(d) or 2(e) ☐
|
|||||
(6)
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
US
|
|||||
NUMBER
OF
SHARES
|
|
(7)
|
|
SOLE VOTING POWER
3,022,752
|
||
BENEFICIALLY
OWNED
BY
|
|
(8)
|
|
SHARED VOTING POWER
0
|
||
EACH
REPORTING
|
|
(9)
|
|
SOLE DISPOSITIVE POWER
3,022,752
|
||
PERSON
WITH
|
|
(10)
|
|
SHARED DISPOSITIVE POWER
0
|
||
(11)
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,022,752
|
|||||
(12)
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see
instructions) ☐
|
|||||
(13)
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.99%
|
|||||
(14)
|
TYPE OF
REPORTING PERSON (see instructions)
IN
|
CUSIP
No. 987537206
|
13D
|
Page
3 of 6
Pages
|
(a)
|
This
Amendment No. 4 to Schedule 13D is being made by Carl
Grover.
|
(b)
|
The
principal business address for the Mr. Grover is 1010 S. Ocean
Blvd. #1017, Pompano Beach, FL 33062.
|
(c)
|
Mr.
Grover is a private investor.
|
(d)
|
Mr.
Grover has not, during the last five years, been convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors).
|
(e)
|
Mr.
Grover has not, during the last five years, been a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject
to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject or, federal or
state securities laws or finding any violation with respect to such
laws.
|
(f)
|
Mr.
Grover is a citizen of the United States of America.
|
CUSIP
No. 987537206
|
13D
|
Page
4 of 6
Pages
|
|
|
(a)
|
The
aggregate number and percentage of shares of the Common Stock to
which this Schedule 13D relates is shares of Common Stock,
constituting approximately 9.99% of the Issuer’s outstanding
Common Stock. The shares consist of (1) a Series C warrant to
purchase 200,000 shares of Common Stock at an exercise price of
$9.00 per share, (2) a Series C warrant to purchase 266,667 shares
of common stock at an exercise price of $9.00 per share, (3)
1,213,629 outstanding shares of Common Shares, (4) 571,428 shares
of common stock issuable upon the conversion of a promissory note
issued in July 2014 in the principal amount of $4,000,000,
convertible at $7.00 per share, (5) a Series A Warrant to purchase
782,608 shares of common stock at an exercise price of $4.60 per
share, (6) 631,579 shares underlying the Exchange Warrant. The
aggregate number and percentage of shares of Common Stock reported
herein are based upon 27,805,500 shares of Common Stock outstanding
as of February 15, 2019. Notwithstanding the provisions of the
Series C Warrants, the Series A Warrants or the Exchange Warrant,
in no event shall the Series C Warrants or the Series A Warrants or
the Exchange Warrant be exercisable into shares of Common Stock to
the extent that the issuance of Common Stock upon the exercise,
after taking into account the Common Stock then owned by the Mr.
Grover, would result in the beneficial ownership by Mr. Grover of
more than 9.99% of the outstanding Common Stock of the Company. For
purposes of this paragraph, beneficial ownership shall be
determined in accordance with Section 13(d) of the Securities
Exchange Act of 1934, as amended.
|
|
|
(b)
|
Mr.
Glover has the sole power to vote or direct the vote of and to
dispose or direct the disposition of the shares of Common Stock
reported as beneficially owned by him herein.
|
(c)
|
See
Item 4 and Annex A hereto, both of which are incorporated by
reference herein.
|
(d)
|
Not
applicable.
|
(e)
|
Not
applicable.
|
Exchange
Agreement, dated October 23, 2018, between Youngevity
International, Inc. and Carl Grover (incorporated by reference to
Exhibit 10.1 of the Issuer’s Current Report on Form 8-K (File
No. 000-54900) filed with the Securities and Exchange Commission on
October 29, 2018)
|
|
|
|
Form of
Warrant Agreement between
Youngevity International, Inc. and Carl Grover (incorporated by
reference to Exhibit 4.1 of the Issuer’s Current Report on
Form 8-K (File No. 000-54900) filed with the Securities and
Exchange Commission on October 29, 2018)
|
|
|
|
Form of
8% Series C Secured Convertible
Promissory Note (incorporated by reference to Exhibit 4.2 of the
Issuer’s Current Report on Form 8-K (File No. 000-54900)
filed with the Securities and Exchange Commission on October 16,
2015)
|
|
|
|
Certain
Transactions by the Reporting Person
|
CUSIP
No. 987537206
|
13D
|
Page
5 of 6
Pages
|
|
/s/ Carl
Grover
|
|
Carl
Grover
|
CUSIP
No. 987537206
|
13D
|
Page
6 of 6
Pages
|
1/14/19
|
|
Acquired
747,664 shares of Common Stock upon shareholder approval of the
Exchange Agreement
|
|
$
|
*
|
|
|
*
|
As
disclosed in this Amendment No. 4, on November 25, 2018 the Issuer
filed a definitive Information Statement on Schedule 14C pursuant
to which the majority shareholders of the Issuer granted the
required shareholder approval under the Exchange Agreement, which
such approval was effective on December 5, 2018 being 20 days after
the mailing date of the Schedule 14C. Following such date, the
Exchange Shares were issued to Mr. Glover.
|